Since the adoption of the ICH M7 guidelines in 2014, pharmaceutical industries have been mandated to screen all reagents and chemicals used in drug synthesis for genotoxicity. Genotoxic impurities (GTIs) have the potential to induce mutations in DNA, which may lead to cancer. Unlike routine impurities, the threshold for controlling GTIs is extremely low. Imipramine hydrochloride (IH) is a commonly used antidepressant; however, the genotoxicity of both the drug and their impurities remain unknown. In this study, we systematically investigate the raw materials, intermediates, and known impurities involved in the synthesis pathway of IH for their potential genotoxicity. We employed in silico prediction tools to evaluate the toxicity of the impurities, intermediates, and raw materials used in the synthesis of IH, in accordance with ICH M7 guidelines. In silico prediction results revealed two specific impurities, 2,2-dinitro-1,2-diphenylethane (DNB) and 2,2-amino-1,2-diphenylethane (DAB), as potentially genotoxic. Furthermore, molecular docking and simulation studies were conducted to evaluate the specific interactions of these impurities with DNA. The results demonstrated consistent interactions of these impurities with the dG-rich region of the DNA duplex, particularly at the minor groove. Both in silico predictions and molecular docking studies corroborated the genotoxic nature of these impurities. As part of our risk assessment and control strategy, we developed and validated an HPLC-UV method in accordance with ICH guidelines to identify both GTIs in the final active pharmaceutical ingredient (API) of imipramine. This study will assist manufacturers of IH in controlling these genotoxic impurities to ensure its safe consumption.
Neonicotinoids are high affinity agonists of insect Nicotinic Acetyl Choline Receptors (nAChRs) resulting in insect paralysis and death. Although they are assumed to have relatively low affinity towards mammalian and other non-insect nAChRs, studies have shown that they can cause neuro-endocrine toxicity, immunotoxicity and endocrine toxicity. Moreover, as a result of bioaccumulation the levels of neonicotinoids can be even traced in non-farming population at an significant level. KCHN2 gene encodes ERG1 or hERG or KV11.1 which is responsible for Ikr current. Multiple chemical molecules can block this KV11.1-alpha sub unit and can result in prolongation of QT interval causing Drug induced Long QT Syndrome (DI-LQTS). This could potentially trigger Torsades de Pointes (TdP), a unique form of the premature ventricular complex which are spontaneous in origin and often result in Sudden Cardiac Death (SCD). Imidacloprid (IMI) is highly bioavailable and undergoes biotransformation by cytochrome p450 monooxygenases (CYP) and aldehyde oxidases (AOX) forming Desnitro-Imidacloprid (DNI) and Imidacloprid-Olefin (IOL). Interestingly, acute poisoning with IMI can result in cardiac features such as ventricular tachyarrhythmias with severe hypotension. Nonetheless, despite of the evidence regarding the toxic bioaccumulation of neonicotinoids, a little is known about their cardiovascular toxicity. Henceforth, the current study aims to understand the effect of imidacloprid and its major metabolites on hERG (KV11.1) channel blockade using molecular docking studies. Findings of the study highlighted that IMI, DNI and IOL can potentially bind to residues like Tyr652 and Phe656 in the pore forming domain and can cause hERG (KV 11.1) blockade.

